As intramuscular TXA administration has been recommended following the Manchester Arena bombing enquiry, the aim of CRASH-4 in providing evidence on TXA in mild traumatic brain injury is crucial in the improvement of emergency medicine care. All strength to our collaborators in joining us on this journey!
After almost doubling the number of patients recruited since our last CRASH-4 newsletter, we can confirm that the trial is recruiting the right group of patients following the review of blinded trial data!
After having recruited over 700 CRASH-4 participants, we are delighted to announce that CRASH-4 has been recommended for funding by the NIHR-HTA programme!
With over three hundred and fifty patients recruited we can finally look at the (blinded) trial data to see if we are recruiting the right group of patients.